Literature DB >> 24068316

Diversity of the clinical presentation of the MMR gene biallelic mutations.

Gaëlle Bougeard1, Laurence Olivier-Faivre, Stéphanie Baert-Desurmont, Julie Tinat, Cosette Martin, Emilie Bouvignies, Stéphanie Vasseur, Frédéric Huet, Gérard Couillault, Pierre Vabres, Florence Le Pessot, Caroline Chapusot, David Malka, Brigitte Bressac-de Paillerets, Mario Tosi, Thierry Frebourg.   

Abstract

Constitutional mismatch repair-deficiency, due to biallelic mutations of MMR genes, results in a tumour spectrum characterized by leukaemias, lymphomas, brain tumours and adenocarcinomas of the gastro-intestinal tract, occurring mostly in childhood. We report here two families illustrating the phenotypic diversity associated with biallelic MMR mutations. In the first family, two siblings developed six malignancies including glioblastoma, lymphoblastic T cell lymphoma, rectal and small bowel adenocarcinoma with onset as early as 6 years of age. We showed that this dramatic clinical presentation was due to the presence of two complex genomic PMS2 deletions in each patient predicted to result into complete PMS2 inactivation. In the second family, the index case presented with an early form of Lynch syndrome with colorectal adenocarcinomas at ages 17 and 20 years, and urinary tract tumours at the age of 25 years. We identified in this patient two MSH6 mutations corresponding to a frameshift deletion and an in frame deletion. The latter was not predicted to result into complete inactivation of MSH6. These reports show that the clinical expression of biallelic MMR mutations depends on the biological impact of the second MMR mutation and that, in clinical practice, the presence of a second MMR mutation located in trans should also be considered in patients suspected to present a Lynch syndrome with an unusual early-onset of tumours.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24068316     DOI: 10.1007/s10689-013-9676-1

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  15 in total

1.  The gastrointestinal phenotype of germline biallelic mismatch repair gene mutations.

Authors:  Carol A Durno; Spring Holter; Philip M Sherman; Steven Gallinger
Journal:  Am J Gastroenterol       Date:  2010-06-08       Impact factor: 10.864

2.  Constitutional mismatch repair-deficiency syndrome.

Authors:  Katharina Wimmer; Christian P Kratz
Journal:  Haematologica       Date:  2010-05       Impact factor: 9.941

3.  Pitfalls in molecular analysis for mismatch repair deficiency in a family with biallelic pms2 germline mutations.

Authors:  C H M Leenen; W R R Geurts-Giele; H J Dubbink; R Reddingius; A M van den Ouweland; C M J Tops; H M van de Klift; E J Kuipers; M E van Leerdam; W N M Dinjens; A Wagner
Journal:  Clin Genet       Date:  2011-01-13       Impact factor: 4.438

Review 4.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

5.  Biallelic mutation of MSH2 in primary human cells is associated with sensitivity to irradiation and altered RAD51 foci kinetics.

Authors:  J Barwell; L Pangon; S Hodgson; A Georgiou; I Kesterton; T Slade; M Taylor; S J Payne; H Brinkman; J Smythe; N J Sebire; E Solomon; Z Docherty; R Camplejohn; T Homfray; J R Morris
Journal:  J Med Genet       Date:  2007-05-04       Impact factor: 6.318

6.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.

Authors:  Leigha Senter; Mark Clendenning; Kaisa Sotamaa; Heather Hampel; Jane Green; John D Potter; Annika Lindblom; Kristina Lagerstedt; Stephen N Thibodeau; Noralane M Lindor; Joanne Young; Ingrid Winship; James G Dowty; Darren M White; John L Hopper; Laura Baglietto; Mark A Jenkins; Albert de la Chapelle
Journal:  Gastroenterology       Date:  2008-05-02       Impact factor: 22.682

7.  Novel biallelic mutations in MSH6 and PMS2 genes: gene conversion as a likely cause of PMS2 gene inactivation.

Authors:  Jessie Auclair; Dominique Leroux; Françoise Desseigne; Christine Lasset; Jean Christophe Saurin; Marie Odile Joly; Stéphane Pinson; Xiao Li Xu; Gilles Montmain; Eric Ruano; Claudine Navarro; Alain Puisieux; Qing Wang
Journal:  Hum Mutat       Date:  2007-11       Impact factor: 4.878

8.  Neurofibromatosis and early onset of cancers in hMLH1-deficient children.

Authors:  Q Wang; C Lasset; F Desseigne; D Frappaz; C Bergeron; C Navarro; E Ruano; A Puisieux
Journal:  Cancer Res       Date:  1999-01-15       Impact factor: 12.701

9.  Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1.

Authors:  M D Ricciardone; T Ozçelik; B Cevher; H Ozdağ; M Tuncer; A Gürgey; O Uzunalimoğlu; H Cetinkaya; A Tanyeli; E Erken; M Oztürk
Journal:  Cancer Res       Date:  1999-01-15       Impact factor: 12.701

10.  Unique mutational profile associated with a loss of TDG expression in the rectal cancer of a patient with a constitutional PMS2 deficiency.

Authors:  P Vasovcak; A Krepelova; M Menigatti; A Puchmajerova; P Skapa; A Augustinakova; G Amann; A Wernstedt; J Jiricny; G Marra; K Wimmer
Journal:  DNA Repair (Amst)       Date:  2012-05-17
View more
  6 in total

1.  Gastrointestinal Findings in the Largest Series of Patients With Hereditary Biallelic Mismatch Repair Deficiency Syndrome: Report from the International Consortium.

Authors:  Melyssa Aronson; Steven Gallinger; Zane Cohen; Shlomi Cohen; Rina Dvir; Ronit Elhasid; Hagit N Baris; Revital Kariv; Harriet Druker; Helen Chan; Simon C Ling; Paul Kortan; Spring Holter; Kara Semotiuk; David Malkin; Roula Farah; Alain Sayad; Brandie Heald; Matthew F Kalady; Lynette S Penney; Andrea L Rideout; Mohsin Rashid; Linda Hasadsri; Pavel Pichurin; Douglas Riegert-Johnson; Brittany Campbell; Doua Bakry; Hala Al-Rimawi; Qasim Kholaif Alharbi; Musa Alharbi; Ashraf Shamvil; Uri Tabori; Carol Durno
Journal:  Am J Gastroenterol       Date:  2016-01-05       Impact factor: 10.864

Review 2.  Milestones of Lynch syndrome: 1895-2015.

Authors:  Henry T Lynch; Carrie L Snyder; Trudy G Shaw; Christopher D Heinen; Megan P Hitchins
Journal:  Nat Rev Cancer       Date:  2015-02-12       Impact factor: 60.716

3.  Detecting inversions in routine molecular diagnosis in MMR genes.

Authors:  Edwige Kasper; Sophie Coutant; Sandrine Manase; Stéphanie Vasseur; Pierre Macquère; Gaëlle Bougeard; Laurence Faivre; Olivier Ingster; Stéphanie Baert-Desurmont; Claude Houdayer
Journal:  Fam Cancer       Date:  2022-01-08       Impact factor: 2.375

4.  Association of MSH6 mutation with glioma susceptibility, drug resistance and progression.

Authors:  Chaoran Xie; Hansong Sheng; Nu Zhang; Shiting Li; Xiangyu Wei; Xuesheng Zheng
Journal:  Mol Clin Oncol       Date:  2016-05-20

Review 5.  The Challenge of Diagnosing Constitutional Mismatch Repair Deficiency Syndrome in Brain Malignancies from Young Individuals.

Authors:  Cristina Carrato; Carolina Sanz; Ana María Muñoz-Mármol; Ignacio Blanco; Marta Pineda; Jesús Del Valle; Estela Dámaso; Manel Esteller; Eva Musulen
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

6.  Novel variants of unknown significance in the PMS2 gene identified in patients with hereditary colon cancer.

Authors:  Raffaella Liccardo; Carlo Della Ragione; Nunzio Mitilini; Marina De Rosa; Paola Izzo; Francesca Duraturo
Journal:  Cancer Manag Res       Date:  2019-07-18       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.